Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab Announces Inclusion Of QINLOCK and NUZYRA In China’s National Reimbursement Drug List

Jan 18 (Reuters) - Zai Lab Ltd  9688.HK :
    * ZAI LAB ANNOUNCES INCLUSION OF QINLOCK® (RIPRETINIB) AND
NUZYRA®
(OMADACYCLINE) IN CHINA’S NATIONAL REIMBURSEMENT DRUG LIST

Source text for Eikon:  ID:nGNX76hgtW 
Further company coverage:  9688.HK

Recent news on Zai Lab

See all news